Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy
Jing Zhu, Meng Xin, Congcong Xu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3193-3205
Open Access | Times Cited: 42

Showing 26-50 of 42 citing articles:

Role of Necroptosis in Central Nervous System Diseases
Hongming Shao, Wenbin Wu, Pei Wang, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 23, pp. 3213-3229
Closed Access | Times Cited: 9
Neuroprotective effect of a Keap1-Nrf2 Protein-Protein Inter-action inhibitor on cerebral Ischemia/Reperfusion injury
Zengxin Qi, Yusheng Tong, Hao Luo, et al.
Bioorganic Chemistry (2023) Vol. 132, pp. 106350-106350
Closed Access | Times Cited: 5
Insight from Linker Investigations: Discovery of a Novel Phenylbenzothiazole Necroptosis Inhibitor Targeting Receptor-Interacting Protein Kinase 1 (RIPK1) from a Phenoxybenzothiazole Compound with Dual RIPK1/3 Targeting Activity
Jingjie Fang, Houzong Yao, Chunlin Zhuang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15288-15308
Closed Access | Times Cited: 5
Rational drug design of CB2 receptor ligands: from 2012 to 2021
Yan-Ran Wu, Jia-qin Tang, Wannian Zhang, et al.
RSC Advances (2022) Vol. 12, Iss. 54, pp. 35242-35259
Open Access | Times Cited: 8
Rational Optimizations of the Marine‐Derived Peptide Sungsanpin as Novel Inhibitors of Cell Invasion
Anpeng Li, Jihua Zou, Xiaobin Zhuo, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 2
Closed Access | Times Cited: 4
Protective Effect of a Novel RIPK1 Inhibitor, Compound 4–155, in Systemic Inflammatory Response Syndrome and Sepsis
Zhong-Yi Ling, Quanzhen Lv, Jiao Li, et al.
Inflammation (2023) Vol. 46, Iss. 5, pp. 1796-1809
Closed Access | Times Cited: 4
Structure-based development of potent and selective type-II kinase inhibitors of RIPK1
Ying Qin, Dekang Li, Chunting Qi, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 319-334
Open Access | Times Cited: 4
Discovery of novel biaryl benzoxazepinones as dual-mode receptor-interacting protein kinase-1 (RIPK1) inhibitors
Y.‐C. XIN, Pengcheng Dai, Hongming Shao, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 100, pp. 117611-117611
Closed Access | Times Cited: 1
Necroptosis and autoimmunity
Lin Peng
Clinical Immunology (2024) Vol. 266, pp. 110313-110313
Closed Access | Times Cited: 1
Profiling of the chemical space on the phenyl group of substituted benzothiazole RIPK3 inhibitors
Yue Xu, Caiquan Liang, Wannian Zhang, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106339-106339
Closed Access | Times Cited: 7
Linker optimization of HEPT derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors: From S=O to CHOR
Qingqing Hao, Ling Xu, Christophe Pannecouque, et al.
Chinese Chemical Letters (2022) Vol. 34, Iss. 4, pp. 107663-107663
Closed Access | Times Cited: 6
A novel gut-restricted RIPK1 inhibitor, SZ-15, ameliorates DSS-induced ulcerative colitis
Yisheng Zeng, Jian Peng, Xiaofang Gao, et al.
European Journal of Pharmacology (2022) Vol. 937, pp. 175381-175381
Closed Access | Times Cited: 6
Design, synthesis and in vitro biological evaluation of marine phidianidine derivatives as potential anti-inflammatory agents
Quan Xu, Ning Zhao, Jin Liu, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 71, pp. 116936-116936
Closed Access | Times Cited: 5
Analysis on benzothiazole necroptosis inhibitors with chiral substitutions in the solvent-accessible region of RIP kinase domain
Hongming Shao, Lijuan Xu, Gechang Li, et al.
Bioorganic Chemistry (2023) Vol. 137, pp. 106647-106647
Closed Access | Times Cited: 2
Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies
Ibolya Czegle, Austin L. Gray, Minjing Wang, et al.
Life (2021) Vol. 11, Iss. 12, pp. 1351-1351
Open Access | Times Cited: 5
Discovery of a Novel Benzimidazole Necroptosis Inhibitor from an In-House Compound Library
Yu Zou, Chai Yue, Hongming Shao, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 03, pp. e283-e293
Open Access
Association of RIPK1 and RIPK2 Gene Polymorphisms with Rheumatoid Arthritis in a Chinese Han Population
Shuang Lv, Yiming Li, Bojian Sun, et al.
The Application of Clinical Genetics (2024) Vol. Volume 17, pp. 159-169
Open Access
Previous Page - Page 2

Scroll to top